ˇ
J. Tauchman, I. Císa rˇ ová, P. St eˇ pni cˇ ka
FULL PAPER
) ppm. 13C{ H} NMR (CDCl
1
): δ = 18.75 (CH
), 71.42 (CH C
), 74.53 (d, JP,C = 5 Hz, CH C
CH), 0.60 mmol), EDC (0.11 mL, 0.60 mmol), (R)-[H
NCH(CHMe
N (0.10 mL, 0.71 mmol),
p
)-8 (orange solid; 169 mg, 64%). Some unre-
H, NH + PPh
2
3
3
3
2
)-
4
7
7
8.19 (CH
3.05 (d, JP,C = 2 Hz, CH C
6.25 (d, 1
P, C = 12 Hz, CP C
), 128.18 (CH PPh
3
CH), 52.21 (OMe), 70.92 (CH C
5
H
5
5
H
H
3
),
), afforded amide (R,S
p
acted (S )-10 was also isolated. Analytical data for (R,S )-8. [α]
2 3
CO Me]Cl (101 mg, 0.60 mmol) and Et
5
H
3
5
3
J
5
H
3
), 80.24 (d, 2
J
P,C = 18 Hz,
p
D
3
1
3
CCONH C
PPh ), 128.31 (d, JP,C = 7 Hz, CH PPh
32.18 (d, JP,C = 18 Hz, CH PPh
PPh
5
H
3
2
), 128.21 (d, JP,C = 6 Hz, CH = –151 (c = 0.5, CHCl
3
). H NMR (CDCl
3
): δ = 1.03 (d, JH,H
), 1.06 (d, JH,H = 6.9 Hz, 3 H, CHMe
(dsept, JH,H = 4.8, 6.8 Hz, 1 H, CHMe ), 3.43 (s, 3 H, OMe), 3.85
(m, 1 H, C ), 4.13 (s, 5 H, C ), 4.46 (dt, J = 0.5, 2.6 Hz, 1 H,
), 4.63 (ddd, JP,H = 2.0, JH,H = 4.8, 8.6 Hz, 1 H, NHCH),
5.15 (dt, J = 1.6, 3.0 Hz, 1 H, C ), 7.12–7.60 (m, 11 H, NH +
): δ = 18.10 (CHMe ), 19.31
), 51.71 (OMe), 57.56 (NHCH), 70.80
=
3
3
2
2
), 129.54 (CH PPh
2
), 6.9 Hz, 3 H, CHMe
2
2
), 2.27
2
), 135.19 (d, 2JP,C = 21 Hz, CH
3
1
2
2
), 136.65 (d, 1JP,C = 9 Hz, Cipso PPh
), 138.50 (d, JP,C = 7 Hz,
1
H
2
2
5
3
5 5
H
C
ipso PPh
2
1
), 169.71 (d, 3JP,C = 4 Hz, CONH), 173.33 (CO
2
Me)
5 3
C H
3
ppm. 31P{ H} NMR (CDCl
): δ = –20.0 (s) ppm. IR (Nujol): ν˜ max
3
5 3
H
1
3
1
=
3325 (w, νNH), 1746 (vs., νCO), 1624 (vs., amide I), 1521 (vs., PPh
2
) ppm. C{ H} NMR (CDCl
), 30.88 (CHMe
), 71.59 (CH C
74.50 (d, JP,C = 4 Hz, CH C
3
2
amide II), 1265 (w), 1193 (m), 1155 (s), 1106 (w), 1050 (w), 1002 (CHMe
2
2
–
1
(w), 909 (w), 819 (m), 743 (vs), 698 (vs), 489 (s), 466 (w) cm . EI (CH C
5
H
5
5
H
3
), 73.64 (d, JP,C = 2 Hz, CH C
), 75.45 (d, JP,C = 11 Hz, CP C
5
H
H
3
),
),
+
·
+
1
MS: m/z (%) = 499 (21) [M] , 468 (5) [M – OMe] , 434 (69) [M –
5
H
3
5
3
+
+
2
C
(
(
5
H
5
] , 412 (64) [M – CH(Me)CO
2
Me] , 397 (8) [M – NHCH- 80.72 (d, JP,C = 20 Hz, CCONH C ), 128.16 (CH PPh
5
H
3
2
), 128.19
P,C = 9 Hz, CH PPh ),
), 132.06 (d, JP,C = 17 Hz, CH PPh ), 135.24 (d,
P,C = 21 Hz, CH PPh ),
), 136.26 (d, 1JP,C = 7 Hz, Cipso PPh
P,C = 7 Hz, Cipso PPh P, C = 4 Hz,
), 170.24 (d, 3
): δ = –20.0
s) ppm. IR (neat): ν˜ max = 3305 (m, νNH), 1745 (vs., νCO), 1656 (vs.,
amide I), 1525 (vs., amide II), 1435 (vs), 1311 (m), 1267 (m), 1206
m), 1161 (m), 1107 (w), 1093 (w), 1069 (w), 1027 (m), 1003 (m),
23 (s), 752 (vs), 699 (vs), 666 (w), 646 (w), 613 (w), 501 (s), 485
+
3
3
Me)CO
84) [Ph
2
Me] , 374 (38), 346 (33), 291 (8), 247 (8), 226 (8), 201
(d,
J
P,C = 6 Hz, CH PPh
129.68 (CH PPh
2
), 128.33 (d,
J
2
+
+
2
2
PO] , 183 (14) [Ph
2
P – 2 H] , 170 (25), 149 (21), 121 (36)
)] , 111 (19), 97 (34), 81 (44), 69 (95), 57 (100). HR MS:
calcd. for C27 PFe 499.0999; found 499.1010.
2
2
+
2
[Fe(C
5
H
5
J
2
2
1
H26NO
3
138.26 (d,
J
2
1
J
3
1
2 3
CONH), 172.01 (CO Me) ppm. P{ H} NMR (CDCl
(
R
p
)-1-(Diphenylphosphanyl)-2-{N-[(S)-1-(methoxycarbonyl)ethyl]-
carbamoyl}ferrocene [(S,R )-7]: The amide (R,S )-7 was prepared
as described above, from (R )-1 (69 mg, 0.17 mmol), HOBt (27 mg,
.20 mmol), EDC (0.03 mL, 0.20 mmol), (S)-[H NCH(CH
CO Me]Cl (30 mg, 0.22 mmol) and Et N (0.03 mL, 0.25 mmol).
Yield: 52 mg (63%) of an orange solid. The NMR spectroscopic
data were identical to those for (R,S )-7. [α] = +156 (c = 0.5,
CHCl ).
(
p
p
p
(
8
(
0
3
3
)
2
3
–1
+·
s), 461 (m) cm . EI MS: m/z (%) = 527 (26) [M] , 496 (10) [M –
+
+
OMe] , 481 (10), 462 (27) [M – C
5
H
5
] , 412 (18) [M – CH(CHMe
2
)-
p
D
+
+
CO
2
Me] , 402 (16), 397 (4) [M – NHCH(CHMe
2
)CO
2
Me] , 346
3
+
+
(
1
11), 201 (23) [Ph
2
PO] , 183 (7) [Ph
2
P – 2 H] , 170 (8), 165 (16),
)] , 97 (22), 83 (100), 69 (53), 57 (81).
PFe 527.1313; found 527.1321.
+
5 5
49 (13), 121 (12) [Fe(C H
(S
p
)-1-(Diphenylphosphanyl)-2-{N-[(S)-1-(methoxycarbonyl)-2-meth-
ylprop-1-yl]carbamoyl}ferrocene [(S,S )-8]: The General Procedure,
with (S )-1 (207 mg, 0.50 mmol), HOBt (81 mg, 0.60 mmol), EDC
0.11 mL, 0.60 mmol), (S)-[H NCH(CHMe )CO Me]Cl (101 mg,
N (0.10 mL, 0.71 mmol), yielded the amide
)-8 as an orange solid (198 mg, 75%). [α] = –195 (c = 0.5,
): δ = 0.64 (d, JH,H = 6.9 Hz, 3 H,
HR MS: calcd. for C29
H
30NO
3
p
p
(
S
p
)-1-(Diphenylphosphanyl)-2-{N-[(S)-1-(methoxycarbonyl)-2-
phenylethyl]carbamoyl}ferrocene [(S,S )-9]: Treatment of (S )-1
207 mg, 0.50 mmol), HOBt (81 mg, 0.60 mmol), EDC (0.11 mL,
0.60 mmol), (S)-[H NCH(CH Ph)CO Me]Cl (131 mg, 0.61 mmol)
and Et N (0.10 mL, 0.71 mmol) according to the General Pro-
cedure gave (S,S )-9 as an orange solid (204 mg, 71%). Single crys-
tals suitable for X-ray diffraction analysis were grown from ace-
(
3
2
2
p
p
0
.60 mmol) and Et
3
(
(
S,S
CHCl
CHMe
4.5, 6.9 Hz, 1 H, CHMe
OMe), 4.22 (s, 5 H, C ), 4.47 (t, J = 2.6 Hz, 1 H, C
ddd, JP,H = 2.2, JH,H = 4.9, 8.8 Hz, 1 H, NHCH), 5.20 (dt, J =
.5, 2.7 Hz, 1 H, C ), 7.11–7.60 (m, 10 H, PPh ), 7.88 (dd, JP,H
13.6, JH,H = 8.7 Hz, 1 H, NH) ppm. C{ H} NMR (CDCl ):
), 30.66
), 71.63
p
D
1
3
3
2
2
3
). H NMR (CDCl
3
3
3
3
2
), 0.83 (d, JH,H = 6.9 Hz, 3 H, CHMe
2
), 2.17 (dsept, JH,H
), 3.80 (s, 3 H,
), 4.63
p
=
2
), 3.77 (m, 1 H, C H
5 3
5
H
5
5 3
H
1
3
tone/diethyl ether at +4 °C. [α]
D
= –198 (c = 0.5, CHCl
3
). H NMR
): δ = 3.02 (dd, JH,H = 7.6, JH,H = 14.0 Hz, 1 H, CH Ph),
Ph), 3.78 (s, 3 H,
), 4.46 (dt, J = 1.0,
), 4.95 (dddd, JP,H = 2.3, JH,H = 5.3, 7.7, 7.7 Hz,
H, NHCH), 5.14 (dt, J = 1.6, 2.7 Hz, 1 H, C ), 6.96–7.61 (m,
), 7.91 (dd, JH,H = 7.8, JP,H = 12.8 Hz, 1 H,
(
1
=
3
2
(
CDCl
3.12 (dd, JH,H = 5.2, JH,H = 14.0 Hz, 1 H, CH
OMe), 3.86 (m, 1 H, C ), 4.09 (s, 5 H, C
3
2
5
H
3
2
3
2
3
13
1
2
3
7
5
H
3
5 5
H
δ = 17.60 (d,
J
P,C = 2 Hz, CHMe
2
), 18.85 (CHMe
2
3
2
1
5 3
.6 Hz, 1 H, C H
(
(
CHMe
CH C
2
), 52.11 (OMe), 57.43 (NHCH), 70.91 (CH C
5
H
5
5
H
3
5
H
3
), 73.83 (d, JP,C = 2 Hz, CH C
5
H
3
), 74.57 (d, JP,C = 4 Hz,
3
), 74.83 (d, 1
2
15 H, CH
NHCH) ppm. C{ H} NMR (CDCl
(OMe), 53.86 (NHCH), 70.90 (CH C
(d, JP,C = 2 Hz, CH C ), 74.62 (d, JP,C = 4 Hz, CH C
(d, 1JP,C = 11 Hz, CP C
), 126.77 (CH CH Ph), 128.08 (CH PPh
5 Hz, CH PPh ), 128.35 (CH CH Ph), 128.35 (d, JP,C = 9 Hz, CH
PPh ), 129.16 (CH CH Ph), 129.81 (CH PPh
), 131.85 (d, 2JP,C
7 Hz, CH PPh ), 136.14 (d,
), 135.36 (d, 2JP,C = 21 Hz, CH PPh
P,C = 6 Hz, Cipso PPh ), 136.17 (Cipso CH
Ph), 138.36 (d, 1JP,C
P,C = 4 Hz, CONH), 172.54
): δ = –20.6 (s) ppm. IR
2 2
Ph + PPh
CH C
5
H
3
JP,C = 9 Hz, CP C
5
H
3
), 80.08 (d,
), 128.36
), 129.81 (CH PPh ),
2
), 135.22 (d, JP,C = 21 Hz, CH
P,C
J =
1
3
1
3
3
): δ = 37.97 (CH
), 71.89 (CH C
2
Ph), 52.27
H
H
1
8 Hz, CCONH C
5 3 2
H ), 128.31 (d, JP,C = 6 Hz, CH PPh
3
5
H
5
5
3
), 73.64
), 75.02
(CH PPh ), 128.41 (d, JP,C = 9 Hz, CH PPh
2
2
2
2
2
5
H
3
5
3
132.07 (d, JP,C = 17 Hz, CH PPh
2
), 135.56 (d, 1JP,C = 6 Hz, Cipso PPh
1
5 3
H ), 79.97 (d, JP,C = 20 Hz, CCONH
PPh
C
2
2
), 137.40 (d, JP,C = 6 Hz,
), 170.70 (d, 3JP,C = 4 Hz, CONH), 172.86 (CO
3
C
5
H
3
2
2
), 128.24 (d, JP,C =
ipso PPh
2
1
2
Me)
3
): δ = –20.0 (s) ppm. IR (neat): ν˜ max
3
ppm. 3 P{ H} NMR (CDCl
1
2
2
2
2
2
=
=
3315 (m, νNH), 1740 (vs., νCO), 1653 (vs., amide I), 1517 (vs.,
amide II), 1310 (m), 1274 (w), 1193 (m), 1160 (m), 1107 (w), 1028
m), 1001 (m), 845 (w), 820 (m), 743 (s), 697 (s), 543 (w), 484 (s)
1
2
2
1
J
2
2
=
(
3
–1
+·
+
6 Hz, Cipso PPh
(CO
2
1
), 170.34 (d, J
cm . EI MS: m/z (%) = 527 (31) [M] , 496 (3) [M – OMe] , 462
Me) ppm. 3 P{ H} NMR (CDCl
1
+
+
2
3
(100) [M – C
5
H
5
] , 412 (64) [M – CH(CHMe
2
)CO
2
Me] , 402 (51),
+
(Nujol): ν˜ max = 3290 (w, νNH), 1751 (vs., νCO), 1647 (vs., amide I),
1524 (s, amide II), 1410 (w), 1308 (m), 1269 (m), 1217 (m), 1203
(w), 1193 (m), 1153 (m), 1106 (m), 1090 (w), 1034 (w), 999 (w), 985
w), 845 (w), 818 (w), 747 (s), 699 (s), 502 (m), 484 (s), 457 (w)
cm . EI MS: m/z (%) = 575 (23) [M] , 544 (5) [M – OMe] , 510
Ph)CO
Me] , 374 (12) [M – Ph
2 2
346 (44), 291 (14), 226 (12), 201 (100) [Ph PO] , 183 (20) [Ph P –
397 (10) [M – NHCH(CHMe
2
)CO
2
Me] , 346 (43), 303 (7), 291 (6),
+
+
247 (6), 226 (10), 201 (85) [Ph
2
PO] , 183 (15) [Ph
2
P – 2 H] , 170
)] , 97 (10), 83 (14), 73 (20), 55
3
30NO PFe 527.1313; found 527.1306.
+
(28), 149 (11), 121 (30) [Fe(C
5 5
H
(
(39). HR MS: calcd. for C29
H
–
1
+·
+
+
+
(
S
p
)-1-(Diphenylphosphanyl)-2-{N-[(R)-1-(methoxycarbonyl)-2-meth- (27) [M – C
)-8]: The General Procedure,
)-1 (207 mg, 0.50 mmol), HOBt (81 mg,
5
H
5
] , 450 (31), 412 (74) [M – CH(CH
2
2
Me] ,
+
+
ylprop-1-yl]carbamoyl}ferrocene [(R,S
starting with (S
p
397 (11) [M – NHCH(CH
2
Ph)CO
2
2
PO] ,
+
p
4284
www.eurjoc.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2010, 4276–4287